» Authors » Eric S H Lau

Eric S H Lau

Explore the profile of Eric S H Lau including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 84
Citations 1128
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lau E, Luk A, Lim L, Wu H, Yang A, Kong A, et al.
Diabetes Care . 2025 Feb; PMID: 39998909
Objective: Patient-level simulation models, mainly developed in Western populations, capture complex interactions between risk factors and complications to predict the long-term effectiveness and cost-effectiveness of novel treatments and identify high-risk...
2.
Lui J, Lau E, Li A, Zhang Y, Lim L, Chun-KwunO , et al.
Diabetes Res Clin Pract . 2024 Dec; 219():111961. PMID: 39701541
Objective: We examined incremental healthcare costs (inpatient and outpatient) related to complications in Chinese patients with type 2 diabetes (T2D) during the year of occurrence and post-event years, utilizing the...
3.
Zhang Y, Tam C, Lau E, Ng N, Yang A, Fan B, et al.
Diabetologia . 2024 Nov; 68(3):526-536. PMID: 39611962
Aims/hypothesis: Insulin requirements in the human body undergo continuous changes in response to growth and development. We assessed the life course relationships between insulin demand and insulin adequacy. Methods: Three...
4.
O C, Fan B, Tsoi S, Tam C, Wan R, Lau E, et al.
Diabetologia . 2024 Nov; 68(2):367-381. PMID: 39579208
Aims/hypothesis: Monogenic diabetes is caused by rare mutations in genes usually implicated in beta cell biology. Common variants of monogenic diabetes genes (MDG) may jointly influence the risk of young-onset...
5.
Yu G, Tam C, Lim C, Shi M, Lau E, Ozaki R, et al.
Diabetologia . 2024 Nov; 68(3):602-614. PMID: 39531041
Aims/hypothesis: Type 2 diabetes is a complex and heterogeneous disease and the aetiological components underlying the heterogeneity remain unclear in the Chinese and East Asian population. Therefore, we aimed to...
6.
Ma R, Tam C, Hou Y, Lau E, Ozaki R, Lui J, et al.
Diabetologia . 2024 Nov; 68(2):342-356. PMID: 39508878
Aims/hypothesis: N-terminal pro B-type natriuretic peptide (NT-proBNP) is a natriuretic peptide that is strongly associated with congestive heart failure (CHF). The utility of NT-proBNP for prediction of cardiovascular events and...
7.
Zhang Y, Wu H, Yang A, Ng N, Zhang X, Lau E, et al.
Clin Endocrinol (Oxf) . 2024 Jul; 101(6):605-613. PMID: 39038182
Objectives: There is relatively scarce data regarding the association between primary hyperparathyroidism (PHPT) and incident diabetes in large population-based longitudinal studies. We aimed to evaluate the risk of incident diabetes...
8.
O C, Fan Y, Fan B, Lim C, Lau E, Tsoi S, et al.
BMJ Open Diabetes Res Care . 2024 Jun; 12(3). PMID: 38901858
Introduction: We designed and implemented a patient-centered, data-driven, holistic care model with evaluation of its impacts on clinical outcomes in patients with young-onset type 2 diabetes (T2D) for which there...
9.
Tsoi S, Lim C, Ma R, Lau E, Fan B, Chow E, et al.
Diabetes Metab Res Rev . 2024 May; 40(5):e3823. PMID: 38821874
Aims: Asians have a high prevalence of young-onset diabetes, but the pattern of monogenic diabetes is unknown. We aimed to determine the prevalence of monogenic diabetes in Chinese patients with...
10.
Cheung J, Yang A, Wu H, Lau E, Lui J, Kong A, et al.
Diabetes Obes Metab . 2024 May; 26(8):3339-3351. PMID: 38802991
Aim: Therapeutic inertia, hypoglycaemia and poor treatment persistence can lead to glycaemic fluctuation and poor outcomes in type 2 diabetes (T2D). We compared glycated haemoglobin (HbA1c) variability, insulin initiation, severe...